Zobrazeno 1 - 10
of 417
pro vyhledávání: '"Piet Ost"'
Autor:
Daniel R. Zwahlen, Christina Schröder, Lisa Holer, Jürg Bernhard, Tobias Hölscher, Winfried Arnold, Bülent Polat, Guido Hildebrandt, Arndt-Christian Müller, Paul Martin Putora, Alexandros Papachristofilou, Corinne Schär, Stefanie Hayoz, Marcin Sumila, Kathrin Zaugg, Matthias Guckenberger, Piet Ost, Davide Giovanni Bosetti, Christiane Reuter, Silvia Gomez, Kaouthar Khanfir, Marcus Beck, George N. Thalmann, Daniel M. Aebersold, Pirus Ghadjar
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 47, Iss , Pp 100786- (2024)
Objectives: To evaluate effects of dose intensified salvage radiotherapy (sRT) on erectile function in biochemically recurrent prostate cancer (PC) after radical prostatectomy (RP). Materials and methods: Eligible patients had evidence of biochemical
Externí odkaz:
https://doaj.org/article/65b24dc90fdc494a9b45ebca159e3feb
Autor:
Renée Bultijnck, Mieke Van Hemelrijck, Valérie Fonteyne, Lorenzo Livi, Barbara Alicja Jereczek-Fossa, Hossein Hemmatazad, Michael Mayinger, Heike Peulen, Luc Verbeke, Sara Ramella, Pablo Castro, Pelagia Tsoutsou, Karin Stellamans, Adnan Shaukat, Miha Orazem, Paul Jeene, Pètra Braam, Helena Verkooijen, Inga-Malin Simek, Filippo Alongi, Enrico Clementel, Catherine Fortpied, Abigirl Machingura, Felix Boakye Oppong, Matthias Guckenberger, Piet Ost
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 45, Iss , Pp 100715- (2024)
Objective: To evaluate the impact of metastases-directed stereotactic body radiotherapy (SBRT) on health-related quality of life (HRQoL) in men with oligometastatic prostate cancer (PCa) using real-world data from the OligoCare cohort. Materials and
Externí odkaz:
https://doaj.org/article/be78d57f043f4f72bc0b6681370905ae
Autor:
Cedric Peters, Julie Vandewiele, Yolande Lievens, Marc van Eijkeren, Valérie Fonteyne, Tom Boterberg, Pieter Deseyne, Liv Veldeman, Wilfried De Neve, Chris Monten, Sabine Braems, Fréderic Duprez, Katrien Vandecasteele, Piet Ost
Publikováno v:
Journal of Bone Oncology, Vol 44, Iss , Pp 100519- (2024)
Background: Despite the encouraging results of the SCORAD trial, single fraction radiotherapy (SFRT) remains underused for patients with complicated bone metastases with rates as low as 18–39%. We aimed to evaluate the incidence and treatment patte
Externí odkaz:
https://doaj.org/article/91b0e8129c6843c69f4d2b4b2defd491
Autor:
Orane Lorton, MS Dipl Ing, Vérane Achard, MD, PhD, Nikolaos Koutsouvelis, MS, Maud Jaccard, MS, PhD, Frederik Vanhoutte, MS, PhD, Giovanna Dipasquale, MS, Piet Ost, MD, PhD, Thomas Zilli, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 6, Pp 101290- (2023)
Purpose: Consistency in delineation of pelvic lymph node regions for prostate cancer elective nodal radiation therapy is still challenging despite current guidelines. The aim of this study was to evaluate the interobserver variability in elective lym
Externí odkaz:
https://doaj.org/article/8cfc44d5160449578794106af8e6438d
Autor:
Jan Vanwelkenhuyzen, Eva Van Bos, Siska Van Bruwaene, Karl Lesage, Alex Maes, Sezgin Üstmert, Filip Lavent, Laurence Beels, Henrik Grönberg, Piet Ost, Johan Lindberg, Bram De Laere
Publikováno v:
European Urology Open Science, Vol 53, Iss , Pp 63-66 (2023)
Lutetium-177 prostate-specific membrane antigen radioligands (177Lu-PSMA) are new therapeutic agents for the treatment of metastatic castration-resistant prostate cancer (mCRPC). We evaluated the prognostic value of circulating tumour DNA (ctDNA) pro
Externí odkaz:
https://doaj.org/article/07f84f7603244e0b9d3eee1e8de33ba6
Autor:
Geert De Kerf, Michaël Claessens, Fadoua Raouassi, Carole Mercier, Daan Stas, Piet Ost, Piet Dirix, Dirk Verellen
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 28, Iss , Pp 100494- (2023)
Background and Purpose: Clinical Artificial Intelligence (AI) implementations lack ground-truth when applied on real-world data. This study investigated how combined geometrical and dose-volume metrics can be used as performance monitoring tools to d
Externí odkaz:
https://doaj.org/article/f047cc880a7148d98829b010a407d729
Autor:
Valérie Fonteyne MD, PhD, Willeke Danckaert Msc, Piet Ost MD, PhD, Charlien Berghen MD, PhD, Katrien Vandecasteele MD, PhD, Ben Vanneste MD, PhD, Kato Rans MD, Nick Liefhooghe MD, Steven Wallaert Msc, Leen Paelinck PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Objectives: The aim is to evaluate the incidental dose to the lymphatic regions in prostate-only radiotherapy (PORT) and to compare hematological outcome between PORT and whole pelvic radiotherapy (WPRT) in node-positive prostate cancer (pN1 PCa), in
Externí odkaz:
https://doaj.org/article/e0bdffbebfa342a88ad485fa5adccc24
Autor:
Flor Verghote, Lindsay Poppe, Sofie Verbeke, Piet Dirix, Maarten Albersen, Gert De Meerleer, Charlien Berghen, Piet Ost, Geert Villeirs, Pieter De Visschere, Kathia De Man, Daan De Maeseneer, Sylvie Rottey, Charles Van Praet, Karel Decaestecker, Valérie Fonteyne
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background The outcome of patients with muscle-invasive bladder cancer (MIBC) remains poor, despite aggressive treatments. Inadequate primary staging, classically performed by computed tomography (CT)-imaging, could lead to inappropriate tre
Externí odkaz:
https://doaj.org/article/bb6642d943504af999d236b8d42f9b98
Autor:
Juho Jasu, Teemu Tolonen, Emmanuel S. Antonarakis, Himisha Beltran, Susan Halabi, Mario A. Eisenberger, Michael A. Carducci, Yohann Loriot, Kim Van der Eecken, Martijn Lolkema, Charles J. Ryan, Sinja Taavitsainen, Silke Gillessen, Gunilla Högnäs, Timo Talvitie, Robert J. Taylor, Antti Koskenalho, Piet Ost, Teemu J. Murtola, Irina Rinta-Kiikka, Teuvo Tammela, Anssi Auvinen, Paula Kujala, Thomas J. Smith, Pirkko-Liisa Kellokumpu-Lehtinen, William B. Isaacs, Matti Nykter, Juha Kesseli, G. Steven Bova
Publikováno v:
European Urology Open Science, Vol 30, Iss , Pp 47-62 (2021)
Background: Systematic identification of data essential for outcome prediction in metastatic prostate cancer (mPC) would accelerate development of precision oncology. Objective: To identify novel phenotypes and features associated with mPC outcome, a
Externí odkaz:
https://doaj.org/article/11491b30f8294e5aade6fdfb5c1a7835
Autor:
Maria Antonia Gómez-Aparicio, Jeannette Valero, Begoña Caballero, Rafael García, Ovidio Hernando-Requejo, Ángel Montero, Alfonso Gómez-Iturriaga, Thomas Zilli, Piet Ost, Fernando López-Campos, Felipe Couñago
Publikováno v:
Current Oncology, Vol 28, Iss 4, Pp 2933-2949 (2021)
Prostate cancer is the most commonly diagnosed cancer among men around the world. Radiotherapy is a standard of care treatment option for men with localized prostate cancer. Over the years, radiation delivery modalities have contributed to increased
Externí odkaz:
https://doaj.org/article/444437458baf4aef91542c241b067dcc